Giant Cell Granuloma of the Anterior Skull Base: Need for Early, Maximal Surgical Excision

Shah, Saurin; Keshri, Amit; Behari, Sanjay; Patadia, Simple; Kumari, Neeraj

doi:10.1007/s12070-015-0831-x

Cited by 7 publications

(4 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[51] Differential diagnosis e differential diagnosis of GCTB includes giant cell reparative granuloma, Paget's disease of the bone, aneurysmal cyst bone, chondroblastoma, chondromyxoid fibroma, nonossifying fibroma, fibrous dysplasia, pigmented villonodular synovitis, foreign body reactions, and brown tumors from hyperparathyroidism. [8,39,42,50] ese pathologies might be differentiated based on clinical history, laboratory tests, and imaging characteristics; nevertheless, a histopathological diagnosis is required. Although not pathognomonic, the common finding in a bone biopsy includes multiple multinucleated giant cells accompanied by ovoid-/spindleshaped stromal cells.…”

Section: Discussionmentioning

confidence: 99%

Surgical management of giant cell tumor invading the occipital bone: A case report and literature review

Bocanegra-Becerra

Showing

Tanta

2022

Surgical Neurology International

View full text Add to dashboard Cite

Background: Giant cell tumor of bone (GCTB) rarely originates in the skull, particularly in the occipital bone. Although benign, it can severely destroy the surrounding tissue and undergo an unpredictable clinical course. We report the successful resection of a GCTB invading the occipital bone in a Hispanic adult woman and present a comprehensive review of the literature on this rare pathology by focusing on the occipital area. Case Description: A 40-year-old Hispanic woman presented with a 3-month history of neck pain and a bulging lesion on the retromastoid area. Brain magnetic resonance imaging (MRI) revealed an extradural, expansive, and contrast-enhancing lesion in the right occipital bone with multiple thin septa and evidence of bleeding. The patient underwent an uneventful gross total resection (GTR) of the lesion. The histopathological examination findings included numerous scattered osteoclast-type giant multinucleated cells. At a 10-month follow-up, the patient has not developed any neurological deficits, impairment of life functioning, or signs of recurrence in MRI. Conclusion: GCTB rarely originates in the skull, being the occipital bone the most infrequent site of presentation. When feasible, total surgical resection effectively reduces the risk of recurrence. Nonetheless, radiation and adjuvant therapies have been employed when GTR could not be achieved. A close follow-up with a brain MRI is advised to control recurrence.

show abstract

Section: Discussionmentioning

confidence: 99%

Surgical management of giant cell tumor invading the occipital bone: A case report and literature review

Bocanegra-Becerra

Showing

Tanta

2022

Surgical Neurology International

View full text Add to dashboard Cite

show abstract

“…The differential diagnosis includes other skull tumors such as metastatic carcinoma [7], osteomyelitis [8], granuloma [9], plasmacytoma [10], meningioma [11], anaplastic meningioma [12], meningeal sarcoma [13], sarcomatoid carcinoma [14], etc.…”

Section: Differential Diagnosismentioning

confidence: 99%

Role of Ultrasound in a Rare Case of Primary Lymphoma of the Cranial Vault

Farina¹,

Iannace²,

Conti³

et al. 2020

SN Compr. Clin. Med.

View full text Add to dashboard Cite

The primary lymphoma of the skull is very rare. We describe a case of a 48-year-old woman with a palpable, soft, painless swelling of the soft tissues of the right frontal region, in absence of neurological symptoms. The ultrasonography showed the presence of solid, very vascularized, subcutaneous, and intra-thecal tissue and bone erosion of the internal and external cranial theca. A CT scan of the skull, thorax, and abdomen was performed to exclude further manifestations of the disease and an MRI examination of the brain to exclude involvement of the intracranial structures. CT and MRI confirmed the presence of the intrathecal and extra-thecal mass that infiltrated the external and internal cranial theca, the scalp, and the epidural region without infiltration of the cerebral cortex. The patient underwent mass removal surgery and histological analysis, which allowed the diagnosis of non-Hodgkin B cell lymphoma.

show abstract

“…First described by Jaffe in 1953 (1), central giant cell granuloma (CGCG) is a very rare intraosseous benign lesion typically of the jaws, however more frequently occurring in the mandible than in the maxilla (2,3). Other regions like the skull base, ethmoid sinus or temporal bone are far less affected, respectively only reported in individual cases (4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(18)(19). The incidence of CGCG is reported with 1.1 to 1.97 per 10 6 (20,21) and a slightly higher frequency in females than males (1.25 vs. 1.05 per 10 6 ) (21).…”

Section: Introductionmentioning

confidence: 99%

Central giant cell granuloma of the temporal bone and temporo-mandibular-joint: a case report

Roth¹,

Meier²,

Ettl³

et al. 2022

Front Oral Maxillofac Med

View full text Add to dashboard Cite

We present a seldom case of a patient with extended central giant cell granuloma (CGCG) of the temporal bone and temporomandibular joint representing a detailed example of diagnostical procedures, surgical approach, histological differentiation, treatment options and follow-up. In general, CGCG is a very rare benign osseous lesion of the jaws, more frequently occurring in the mandible than the maxilla. Other regions, such as skull base, ethmoid sinus or temporal bone, are far less common and only seldomly reported.Patients are usually younger than 30 years with a slightly higher occurrence rate in females than males.CGCG usually presents as unspecific incidental radiological finding or with unspecific clinical symptoms, e.g., indolent swelling. Lesions can show aggressive behaviour. Its aetiology remains unclear, syndromic occurrence is reported. Final diagnosis of CGCG is based on histopathological and molecular findings but remains difficult due to numerous differential diagnoses. Surgical therapy is the most common treatment, nevertheless other treatment modalities including several primary and adjuvant drug therapies, e.g., topical injection of steroids, systemic calcitonin, interferon-α, RANKL-inhibitors and tyrosine kinase inhibitors, as well as radiotherapy have been discussed with varying effects. Though, recurrence rates differ widely and range up to 72%. Due to the rarity of CGCG randomized controlled trials are still missing.

show abstract

Giant Cell Granuloma of the Anterior Skull Base: Need for Early, Maximal Surgical Excision

Cited by 7 publications

References 7 publications

Surgical management of giant cell tumor invading the occipital bone: A case report and literature review

Surgical management of giant cell tumor invading the occipital bone: A case report and literature review

Role of Ultrasound in a Rare Case of Primary Lymphoma of the Cranial Vault

Central giant cell granuloma of the temporal bone and temporo-mandibular-joint: a case report

Contact Info

Product

Resources

About